Mihai Miron gains 47m euros on Stock Exchange in four months

The market value of Ropharma Braşov (IAFR) retail pharmacy network, owed by businessman Mihai Miron, has over the past four months climbed by 53m euros on the Stock Exchange, with the company currently valued at 94.1m euros. Thus, the value of the 88% stake in Ropharma Miron owns directly and indirectly has risen by 47m euros.

The drug distributor, which announced it moved to the tier 1 of the Stock Exchange, has thus become the biggest listed pharmaceutical company, leaving far behind companies that are better known on the market, such as Zentiva Bucureşti (SCD), which has a 77m-euro capitalisation, Antibiotice Iaşi (ATB) or Biofarm Bucureşti (BIO).
"I've worked in the pharmaceutical industry ever since the fall of communism and I am a little dissatisfied the pharmaceutical sector, a star on international stock markets, has had a low profile in our country. I hope that by listing Ropharma on the first tier of the Stock Exchange we should stir investors' interest in this field," stated Mihai Miron.